Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line
Authors
Keywords
-
Journal
Biomedicines
Volume 11, Issue 1, Pages 8
Publisher
MDPI AG
Online
2022-12-21
DOI
10.3390/biomedicines11010008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer-on-a-Chip: Models for Studying Metastasis
- (2022) Xiaojun Zhang et al. Cancers
- Targeting MDK Abrogates IFN-γ-Elicited Metastasis inCancers of Various Origins
- (2022) Luyu Zheng et al. Frontiers in Oncology
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
- (2021) Elina A. Pietilä et al. Nature Communications
- Advanced Materials and Sensors for Microphysiological Systems: Focus on Electronic and Electro‐optical Interfaces
- (2021) Hanie Kavand et al. ADVANCED MATERIALS
- Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors
- (2021) M. Bartoletti et al. CANCER TREATMENT REVIEWS
- A highly annotated database of genes associated with platinum resistance in cancer
- (2021) Dongqing Huang et al. ONCOGENE
- Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer
- (2020) Rebeca Gonzalez-Pastor et al. CANCER GENE THERAPY
- High-throughput approaches for precision medicine in high-grade serous ovarian cancer
- (2020) Meinusha Govindarajan et al. Journal of Hematology & Oncology
- Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state
- (2020) Daniela Cerezo-Wallis et al. NATURE MEDICINE
- Roles of IFN-γ in tumor progression and regression: a review
- (2020) Dragica Jorgovanovic et al. Biomarker Research
- HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer
- (2020) Rita Lombardi et al. Molecular Oncology
- High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
- (2019) Michael-Antony Lisio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IFNγ, a Double-Edged Sword in Cancer Immunity and Metastasis
- (2019) Chengfei Liu et al. CANCER RESEARCH
- Low-dose IFN-γ induces tumor cell stemness in the tumor microenvironment of non-small cell lung cancer
- (2019) Mengjia Song et al. CANCER RESEARCH
- A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial–mesenchymal transition in tumor metastasis
- (2019) Lina Li et al. ONCOGENE
- Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target
- (2019) Panagiota S. Filippou et al. ONCOGENE
- Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
- (2018) Shan-Shan Li et al. Journal of Gynecologic Oncology
- Ovarian Cancer Prevention and Screening
- (2018) Usha Menon et al. OBSTETRICS AND GYNECOLOGY
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- IFN-r-induced IFIT5 promotes epithelial-to-mesenchymal transition in prostate cancer via microRNA processing
- (2018) U-Ging Lo et al. CANCER RESEARCH
- The Interferon-Gamma Paradox in Cancer
- (2018) M. Raza Zaidi JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Improved therapeutic efficacy of mammalian expressed-recombinant interferon gamma against ovarian cancer cells
- (2017) Ali Razaghi et al. EXPERIMENTAL CELL RESEARCH
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- SnapShot: Interferon Signaling
- (2015) Kwan T. Chow et al. CELL
- A short 2 week dose titration regimen reduces the severity of flu-like symptoms with initial interferon gamma-1b treatment
- (2014) John G. Devane et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Two Faces of Interferon- in Cancer
- (2011) M. R. Zaidi et al. CLINICAL CANCER RESEARCH
- Effect of plasmid-mediated stable interferon-γ expression on proliferation and cell death in the SKOV-3 human ovarian cancer cell line
- (2011) Huiming Lv et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Clinical Use of Interferon-γ
- (2009) Catriona H.T. Miller et al. Annals of the New York Academy of Sciences
- Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival
- (2008) David S. Alberts et al. GYNECOLOGIC ONCOLOGY
- IFN-γ withdrawal after immunotherapy potentiates B16 melanoma invasion and metastasis by intensifying tumor integrin αvβ3 signaling
- (2008) Wei Gong et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started